Question

A 66-year-old man with chronic kidney disease stage 3b is reviewed in clinic. His eGFR is 38 mL/min/1.73 m² and ACR is 45 mg/mmol. He is already on an ACE inhibitor for hypertension. According to NICE CKD guidance, which additional intervention is most appropriate to reduce progression risk?

Accepted Answer

Add an SGLT2 inhibitor if no contraindication

Answer

Stop ACE inhibitor to avoid further decline in eGFR

Answer

Advise tight glycaemic control even though he is not diabetic

Answer

Give high-protein dietary supplements

Answer

Avoid statins as they worsen renal function

Practice question

A 66-year-old man with chronic kidney disease stage 3b is reviewed in clinic. His eGFR is 38 mL/min/1.73 m² and ACR is 45 mg/mmol. He is already on an ACE inhibitor for hypertension. According to NICE CKD guidance, which additional intervention is most appropriate to reduce progression risk?